对于心血管疾病风险患者的生活方式改变的Petal-x可视化:评估
Adrijana Svenšek1, Diego Rojo2, Lucija Gosak1
1University of Maribor, Faculty of Health Sciences, Maribor, Slovenia.
Studies in health technology and informatics
|August 8, 2025
概括
在一项为期六个月的研究中,使用Petal-X仪表板可视化心血管疾病 (CVD) 风险并没有显著降低10年的心血管疾病风险. 然而,趋势表明,积极改变生活方式和适度降低风险有潜在的益处.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 医疗信息学 医疗信息学
背景情况:
- 心血管疾病 (CVD) 是全球主要的健康负担,需要有效的降低风险策略.
- 不健康的生活方式是心血管疾病的主要驱动因素,使患者的教育和动机对预防至关重要.
- 个性化患者护理可以通过视觉工具来增强,这些工具可以提高对健康风险的理解,并鼓励行为修改.
研究的目的:
- 评估使用SCORE2模型的Petal-X仪表板在促进生活方式变化和降低10年心血管疾病风险方面的有效性.
- 评估视觉风险评估工具是否可以激励患者采取更健康的行为.
- 为了确定可视化心血管风险评分对患者结果的影响.
主要方法:
- 在斯洛文尼亚的一个社区卫生中心进行了一项涉及52名参与者的随机对照试验 (RCT).
- 参与者被分配到各个小组,以评估Petal-X仪表板在六个月内的影响.
- 主要结局指标是SCORE2 10年心血管疾病风险评分的变化.
主要成果:
- 干预组和对照组在降低SCORE2风险评分方面没有观察到统计学上显著的差异 (χ2 = 0.879; p = 0.348).
- 其他测量结果也显示,两组之间没有显著差异.
- 一个积极的趋势表明,SCORE2可视化可能在降低心血管疾病风险方面提供适度的好处.
结论:
- 尽管在本研究中,Petal-X仪表板没有显示出显著的风险降低,但它显示出一种趋势,即适度的益处.
- 想象心血管疾病风险可能在激励改变生活方式方面发挥作用.
- 建议对更大样本和更长的随访期进行进一步的研究,以确认这些工具的潜在益处.
相关概念视频
01:26Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
01:23Assessment of the Cardiovascular System I: Subjective Data
467
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
467
01:26Coronary Artery Disease IV: Preventive Measures
34
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
34
01:27Coronary Artery Disease V: Interprofessional Care
33
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
33
01:27Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
334
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
334